Oligometastatic non‐small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome

Oligometastatic (OMD) non‐small cell lung cancer (NSCLC) is a distinct but heterogeneous entity. Current guidelines recommend systemic therapy and consolidation with local ablative therapy (LAT). However, evidence regarding the optimal choice of multimodal treatment approaches is lacking, in particu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2025-02, Vol.156 (4), p.776-787
Hauptverfasser:	Wiesweg, Marcel, Küter, Claudia, Schnorbach, Johannes, Keyl, Julius, Metzenmacher, Martin, Cvetkovic, Jelena, Saalfeld, Felix Carl, Glanemann, Franziska, Eberhardt, Wilfried, Oezkan, Filiz, Theegarten, Dirk, Stenzinger, Albrecht, Darwiche, Kaid, Koschel, Dirk, Herth, Felix, Bölükbas, Servet, Winter, Hauke, Weykamp, Fabian, Wermke, Martin, Stuschke, Martin, Plönes, Till, Thomas, Michael, Schuler, Martin, Christopoulos, Petros
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Cancer therapies Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Chemotherapy Combined Modality Therapy Female Humans Immune checkpoint inhibitors Immunotherapy Immunotherapy - methods locally ablative treatment Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - therapy Male Metastases Metastasis Middle Aged multimodal concepts Neoplasm Metastasis Non-small cell lung carcinoma observational study oligometastatic NSCLC Patients RESEARCH ARTICLE Retrospective Studies Sensory integration Small cell lung carcinoma Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!